Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AptarGroup, Inc. Common Stock
(NY:
ATR
)
156.09
-0.32 (-0.20%)
Official Closing Price
Updated: 7:00 PM EST, Jan 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
231,872
Open
156.97
Bid (Size)
155.57 (1)
Ask (Size)
156.59 (1)
Prev. Close
156.41
Today's Range
155.68 - 157.95
52wk Range
128.05 - 178.03
Shares Outstanding
65,959,499
Dividend Yield
1.15%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Sixth Consecutive Year
January 14, 2025
From
AptarGroup, Inc.
Via
Business Wire
Top 3 Materials Stocks That Are Set To Fly This Month
January 10, 2025
Via
Benzinga
Performance
YTD
+1.25%
+1.25%
1 Month
-1.32%
-1.32%
3 Month
-6.16%
-6.16%
6 Month
+6.05%
+6.05%
1 Year
+18.98%
+18.98%
More News
Read More
Aptar Announces 2025 Quarterly Conference Call Dates
January 08, 2025
From
Aptar
Via
Business Wire
Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025
January 06, 2025
From
AptarGroup, Inc.
Via
Business Wire
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
January 01, 2025
Via
Benzinga
How Is The Market Feeling About AptarGroup?
December 24, 2024
Via
Benzinga
$1000 Invested In AptarGroup 20 Years Ago Would Be Worth This Much Today
December 24, 2024
Via
Benzinga
Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes
November 13, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Reports Third Quarter 2024 Results
October 24, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
October 22, 2024
From
AptarGroup, Inc.
Via
Business Wire
How Is The Market Feeling About AptarGroup?
September 13, 2024
Via
Benzinga
Looking Into AptarGroup's Recent Short Interest
July 22, 2024
Via
Benzinga
How Is The Market Feeling About AptarGroup?
June 18, 2024
Via
Benzinga
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
October 14, 2024
Via
Benzinga
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
October 10, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
September 23, 2024
From
AptarGroup, Inc.
Via
Business Wire
Green Day Has The Right Idea As September Seasonality Comes In Hot
September 07, 2024
Via
Talk Markets
Topics
ETFs
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
August 15, 2024
From
AptarGroup, Inc.
Via
Business Wire
ATR Stock Earnings: AptarGroup Beats EPS, Misses Revenue for Q2 2024
July 25, 2024
Via
InvestorPlace
Daniel Ackerman Named Aptar’s Chief Accounting Officer
July 25, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
July 25, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Reports Second Quarter 2024 Results
July 25, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
July 11, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Named One of the World’s Most Sustainable Companies 2024 by TIME
June 25, 2024
From
AptarGroup, Inc.
Via
Business Wire
Aptar Named One of America’s Climate Leaders by USA Today
June 06, 2024
From
AptarGroup, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.